CRNM bleeding events
Showing 1 - 25 of >10,000
Venous Thromboembolism and Bleeding Events inPopulation of Obese
Not yet recruiting
- Venous Thromboembolism
- (no location specified)
Apr 6, 2023
Outcomes After Gastrointestinal Bleeding
Recruiting
- Gastrointestinal Hemorrhage
- Cardiovascular Diseases
-
Hamilton, Ontario, CanadaHamilton Health Sciences, PHRI
Sep 29, 2022
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in United States (coagulation factor VIIa [recombinant]-jncw)
Recruiting
- Hemophilia A With Inhibitor
- Hemophilia B With Inhibitor
- coagulation factor VIIa [recombinant]-jncw
-
Phoenix, Arizona
- +23 more
Aug 10, 2022
Atrial Fibrillation (AF), Stroke Trial in Worldwide (Abelacimab, Rivaroxaban)
Active, not recruiting
- Atrial Fibrillation (AF)
- Stroke
- Abelacimab
- Rivaroxaban
-
Huntsville, Alabama
- +93 more
Jan 25, 2023
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Detroit (Abelacimab, Dalteparin)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Dalteparin
-
Detroit, MichiganHenry Ford Health System
Jul 18, 2022
Venous Thromboembolism, Anticoagulant-induced Bleeding, Venous Thromboses Trial in Metepec (Rivaroxaban 20 MG [Xarelto], Aspirin
Completed
- Venous Thromboembolism
- +3 more
- Rivaroxaban 20 MG [Xarelto]
- +2 more
-
Metepec, Estado De Mexico, MexicoInstituto Mexicano Del Seguro Social
Aug 24, 2022
MACCE According to Time Interval of Taking Medication in Acute
Completed
- Acute Coronary Syndrome or B Cerebral Infarction Requiring DAPT(Clopidogrel + Aspirin) for at Least 6 Months
- Esomezol Cap
-
Seoul, Korea, Republic ofHanmi Pharmaceutical Company Limited
Aug 2, 2022
COVID-19, Thrombosis Embolism, Bleeding Trial in Stockholm (Dexamethasone)
Completed
- COVID-19
- +2 more
-
Stockholm, Stockholms Län, SwedenSödersjukhuset
Jun 24, 2022
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Canada, United States (Abelacimab, Apixaban)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Apixaban
-
Lexington, Kentucky
- +2 more
Jun 6, 2022
Chronic Kidney Diseases, Cardiovascular Diseases, Bleeding Trial in Nottingham (Aspirin)
Recruiting
- Chronic Kidney Diseases
- +2 more
-
Nottingham, United KingdomNottingham Digestive Diseases Centre
Jan 3, 2022
Coronary Artery Disease, Percutaneous Coronary Intervention, Acute Coronary Syndrome Trial in Seoul (PPI, P-CAB 25, P-CAB 50)
Recruiting
- Coronary Artery Disease
- +3 more
- PPI
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Mar 6, 2022
Anticoagulation Length of ThErapy and Risk of New Adverse evenTs
Completed
- Venous Thromboembolism
- Anticoagulants and Bleeding Disorders
- Oral Anticoagulant
-
Oakland, California
- +1 more
Oct 31, 2022
The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial
Recruiting
- The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation
- Watchman FLX Device
-
Aarhus, DenmarkAarhus University Hospital
Jan 26, 2023
Atrial Fibrillation Trial in Warsaw (short postimplantation dual antiplatelet therapy, extended postimplantation dual
Recruiting
- Atrial Fibrillation
- short postimplantation dual antiplatelet therapy
- +3 more
-
Warsaw, Mazowieckie, PolandNational Institute of Cardiology
Dec 14, 2022
Thromboembolic Events in Patients Receiving Kcentra® or Plasma
Completed
- Hemorrhage
- Kcentra®
- Plasma
-
Oakland, CaliforniaStudy Site
May 24, 2021
Pancreatitis, Acute, Bleeding, Cholangitis Trial in Helsinki, Turku (endoscopic short duration papillary large balloon dilation)
Recruiting
- Pancreatitis, Acute
- +2 more
- endoscopic short duration papillary large balloon dilation
-
Helsinki, Finland
- +1 more
Oct 12, 2021
Thrombolysis, Symptomatic Proximal Deep Vein Thrombosis Trial in Worldwide (BAY3018250, Placebo to BAY3018250)
Not yet recruiting
- Thrombolysis
- Symptomatic Proximal Deep Vein Thrombosis
- BAY3018250
- Placebo to BAY3018250
-
Antwerpen, Belgium
- +43 more
Nov 28, 2023
Cardiac Disease Trial in Worldwide (Edoxaban, Standard of Care (SOC))
Atrial Fibrillation Trial in Warsaw (short postimplantation dual antiplatelet therapy, extended postimplantation dual
Recruiting
- Atrial Fibrillation
- short postimplantation dual antiplatelet therapy
- +3 more
-
Warsaw, Mazowieckie, PolandNational Institute of Cardiology
Jun 30, 2022
Renal Dialysis Trial in Worldwide (BAY1213790, 0.9% sodium chloride solution)
Completed
- Renal Dialysis
- BAY1213790
- 0.9% sodium chloride solution
-
Chula Vista, California
- +14 more
Mar 15, 2022
Bleeding From Teeth, Bleeding Prophylaxis Trial in Worldwide (Tranexamic acid)
Recruiting
- Bleeding From Teeth
- Bleeding Prophylaxis
- Tranexamic acid
-
Loma Linda, California
- +18 more
Nov 21, 2023
Cirrhosis, Coagulopathy Trial (ROTEM, Conventional Therapy)
Completed
- Cirrhosis
- Coagulopathy
- ROTEM
- Conventional Therapy
- (no location specified)
Dec 31, 2020
Prevention of Venous Thrombosis After TKA Trial in Beijing (SHR2285 tablet, Enoxaparin)
Recruiting
- Prevention of Venous Thrombosis After TKA
- SHR2285 tablet
- Enoxaparin
-
Beijing, Beijing, ChinaPerking Union Medical College Hospital
Mar 18, 2022